Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.36 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | APLNR | P35414 | 1/20 | 0.31 |
| ▸ | SCN4A | P35499 | 3/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9102591 | 0.88 | CYP3A4 (0.59) | CYP3A4ALDH1A1HPGDTDP1TRPA1 | |
| SCHEMBL1332133 | 0.81 | CYP3A4 (0.57) | CYP3A4ALDH1A1HPGDTDP1KDM4E | |
| SCHEMBL30438740 | 0.81 | CYP3A4 (0.57) | CYP3A4ALDH1A1HPGDTDP1KDM4E | |
| SCHEMBL16707539 | 0.81 | CYP3A4 (0.52) | CYP3A4ALDH1A1HPGDTDP1TRPA1 | |
| SCHEMBL3548255 | 0.80 | CYP3A4 (0.50) | CYP3A4ALDH1A1HPGDTDP1TRPA1 | |
| SCHEMBL7534773 | 0.77 | CYP3A4 (0.56) | CYP3A4ALDH1A1HPGDTDP1TRPA1 | |
| SCHEMBL93192 | 0.76 | CYP3A4 (0.79) | CYP3A4ALDH1A1HPGDTDP1TRPA1 | |
| SCHEMBL29440559 | 0.76 | CYP3A4 (0.79) | CYP3A4ALDH1A1HPGDTDP1TRPA1 | |
| SCHEMBL1513786 | 0.76 | CYP3A4 (0.46) | CYP3A4ALDH1A1HPGDTDP1TRPA1 | |
| SCHEMBL93287 | 0.76 | CYP3A4 (0.64) | CYP3A4ALDH1A1HPGDTDP1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105339359-B | Terazololine-one compound and application thereof | 住友化学株式会社 | 2018-02-16 | — | — | CN | disclosed |
| CN-107001244-A | The manufacture method of isocyanate compound | 住友化学株式会社 | 2017-08-01 | — | — | CN | disclosed |
| CN-107001244-A | The manufacture method of isocyanate compound | 住友化学株式会社 | 2017-08-01 | — | — | CN | disclosed |
| US-8754107-B2 | Aminopyrrolidines as chemokine receptor antagonists | ABBVIE INC. (US) | 2014-06-17 | — | — | US | disclosed |
| US-20080176883-A1 | Antiinflammtory, antiproliferative, anticancer agents; (3-Hydroxy-pyrrolidin-1-yl)-(3-trifluoromethyl-7,8-dihydro-5H-[1,6]naphthyridin-6-yl)-methanone | ABBVIE INC. | 2008-07-24 | — | — | US | disclosed |
| US-4437919-A | POLYISOCYANATE, ENDCAPPED POLYETHERSILOXANE | FIBER INDUSTRIES, INC. (US) | 1984-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080176883-A1 | Antiinflammtory, antiproliferative, anticancer agents; (3-Hydroxy-pyrrolidin-1-yl)-(3-trifluoromethyl-7,8-dihydro-5H-[1,6]naphthyridin-6-yl)-methanone | MIF, CCL5, CCR2 | CYP3A4 916/4885ALDH1A1 433/4885HPGD 65/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.